BTMD
biote Corp.
NASDAQ · Healthcare · Medical - Care Facilities · US
$1.55
−0.32%Year over year
Reported trailing growth
- Revenue
- -7.8%
- EBITDA
- -56.9%
- EBIT
- -58.3%
- EPS
- -83.2%
- Free cash flow
- -43.7%
- Operating cash flow
- -41.3%
Forward estimates
Based on analyst estimates
- Revenue
- -2.4%
- EBITDA
- -24.0%
- EPS
- -16.1%
Three-year CAGR
- Revenue
- +5.2%
- EBITDA
- +87.2%
- EBIT
- +11.4%
- Net income
- +185.6%
- EPS
- +157.2%
- Free cash flow
- +11.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026